ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Net Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹129 Cr | ₹144 Cr | ₹408 Cr | ₹394 Cr | ₹-1,578 Cr |
What is the latest Net Current Assets ratio of ORCHID PHARMA ?
Year | Net Current Assets |
---|---|
Mar2023 | ₹129 Cr |
Mar2022 | ₹144 Cr |
Mar2021 | ₹408 Cr |
Mar2020 | ₹394 Cr |
Mar2019 | ₹-1,578 Cr |
How is Net Current Assets of ORCHID PHARMA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹129 Cr | -10.07 | |
Mar2022 | ₹144 Cr | -64.79 | |
Mar2021 | ₹408 Cr | 3.39 | |
Mar2020 | ₹394 Cr | Positive | |
Mar2019 | ₹-1,578 Cr | - |
Compare Net Current Assets of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹5,204.6 Cr | 0.6% | 3.6% | 158.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.4% | 0.8% | 66.3% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 6.4% | 10.5% | 61.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5.1% | 9% | 31.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | 3.2% | 13.1% | 117.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 1.6% | -1% | 33.8% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | 0.6% |
3.6% |
158.7% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses